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Invasive procedures, such as surgery and acupuncture, are likely better than the others in terms of eliciting placebo analgesia.
Understanding how invasive procedures can elicit enhanced placebo responses may provide new insights into mechanisms
underlying placebo analgesia. In this essay, it is argued that sensory, cognitive and emotional factors are major determinants of
the magnitude of placebo analgesia. Sham surgery and acupuncture are good examples of placebo interventions, which generate
robust placebo responses through simultaneouslymanipulating such three factors.
1.Introduction
Althoughthe intensity of pain correlates well with the degree
of noxious stimulation, the perception of pain is not a linear
phenomenon, reﬂecting the signal from peripheral nocicep-
tors [1, 2], but rather heavily shaped by the psychosocial
context in which pain presents itself [3–5]. A striking
example is placebo analgesia which has increasingly been
a research focus [6–10] for the potential of leading to the
development of novel approaches to the control of chronic
pain [11, 12]. Placebo analgesia does not happen all the
time and varies greatly across clinical and experimental
contexts. The essential question has been how and when
placebo analgesia is powerful and if placebo analgesia can
have clinical relevancy. Interestingly, sophisticated, invasive
and painful interventions such as surgery and acupuncture
are thought to have enhanced placebo eﬀects [13–16].
Understanding how invasive procedures can elicit enhanced
placebo responses may provide new insights into mecha-
nisms underlying placebo analgesia.
AcupunctureisanancientChinese therapy with itsmode
ofactionunclearandeﬃcacyinconclusive[17,18].Although
acupuncturehas beendeﬁned assimplistically asthe practice
of inserting one or more needles into speciﬁc sites on the
body surface for therapeutic purposes, converging evidence
from theory basis, clinical practice and clinical and basic
science research of acupuncture supports that acupuncture
has more than needling with its underlying cognitive and
emotional context being an integral part of this therapy [19].
But individual contributions of diﬀerent components of
acupunctureto itstherapeuticeﬀectsremain to beidentiﬁed.
In the following, it is argued that cognitive, sensory and
emotional factors codetermine the magnitude of placebo
analgesia. Hence, enhanced placebo analgesia can be elicited
through manipulating such three factors. Sham surgery and
acupuncture are good examples of placebo interventions,
which generaterobust placebo responses through simultane-
ously engaging sensory, cognitive and emotional factors.
2.FactorsThat Determine the Magnitudeof
Placebo Analgesia
There is no doubt that changes in pain cognition (e.g.
expectations and beliefs for pain) are fundamental factors
underlying placebo analgesia. Expectations for reduced pain
trigger placebo analgesia, and higher levels of less negative
expectations tend to produce larger placebo analgesic eﬀects
[20]. However, expectations alone have not always been
found to produce placebo eﬀects [21], and the magnitude
of placebo analgesia has been reported to be subject to
the inﬂuences of other factors. For example, an early
study showed larger placebo eﬀects with more intense pain,
indicating that sensory factors contribute signiﬁcantly to the
magnitude of placebo analgesia [22]. Moreover, it has been
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aplaceboeﬀectwhen theyarefeelinganxiousthanwhenthey
are not [23, 24], supporting that emotional factors such as
anxiety are other major determinants of the magnitude of
placebo analgesia [25]. Why have there been these diﬀerent
approaches to mechanisms underlying placebo analgesia?
One possible explanation is that, although it is a critical
factor underlying placebo analgesia, expectation is not likely
to operate alone [26, 27], but sensory and emotional factors
are also involved in expectation-based placebo analgesia. In
fact, the rationale to assume that sensory, cognitive and
emotional factors are involved in placebo analgesia lies in the
consideration that placebo analgesia is the consequence of
the same painful stimulus presented in a changed cognitive
and emotional context. Placebo analgesia is triggered by cog-
nitive factors but heavily shaped by concurrent sensory and
emotional factors—that is, sensory, cognitive and emotional
factors are major determinants of the magnitude of placebo
analgesia. These three factors vary greatly across clinical and
research contexts, which may account for the considerable
variability in the placebo eﬀect itself.
3.FactorsThatContributeto Placebo-Induced
ActivationofEndogenousOpioids
3.1. Role of Endogenous Opioids in Placebo Analgesia.
Although both opioid and non-opioid mechanisms are
responsible for placebo analgesia [28], an emerging idea is
that expectation-based placebo eﬀects are opioid-mediated,
but conditioned placebo eﬀects may depend on other mech-
anisms [7, 29–31]. Early pharmacological studies show that
placebo analgesia is antagonized by the opioid antagonist
naloxone [32, 33]. Additionally, the opioid-mediated anal-
gesicplaceboresponse isenhancedwith proglumide,achole-
cystokinin antagonist that modulates opioid activity [34].
Neuroimagingstudiesrevealthatplacebo aﬀectsendogenous
opioid activity in a number of µ-opioid receptor regions that
play central roles in pain and aﬀect [7, 35], and the same
regions of the brain are aﬀected by both a placebo and the
opioidagonist remifentanil, indicating a shared brain mech-
anisminvolvedinplacebo-andopioid-inducedanalgesia[9].
These ﬁndings support a strong role for endogenous opioids
in placebo analgesia, and the extent to which endogenous
opioids are activated may determine the magnitude of
placebo analgesia. However, little is known about how
opioid mechanisms come into play in expectation-based
placebo analgesia, and factors that determine the functional
state of placebo-activated endogenous opioids remain to be
identiﬁed.
3.2. Individual Contributions of Sensory, Cognitive, and Emo-
tional Factors to Placebo-Induced Activation of Endogenous
Opioids. Given that, as outlined above, cognitive, sensory
andemotionalfactorscodeterminethemagnitudeofplacebo
analgesia, it appears reasonable to propose that these three
factors are major determinants of the magnitude of placebo-
induced activation of endogenous opioids. When and only
when these three factors are simultaneously brought into full
play, can endogenous opioids be most eﬀectively activated.
One of the more informative discoveries about placebo-
activated endogenous opioids is that highly spatial-speciﬁc
placebo responses, which are totally blocked by the opioid
antagonist naloxone, can only be obtained in the site of
the ongoing pain which is the target of spatially directed
expectation of pain reduction [20, 29, 36]. This suggests
that placebo-activated endogenous opioids have a precise
and somatotopic organization and, more importantly, the
location of the ongoing pain determines how endogenous
opioids are somatotopically activated, hence in which body
parts placebo analgesic eﬀects occur.
Taken together, sensory, cognitive and emotional factors
contribute diﬀerently to placebo analgesia through deter-
mining diﬀerent aspects of the functional state of placebo-
activated endogenous opioids: the intensity of painful stim-
ulation, the level of expectations for pain reduction and the
degree of fear and anxiety induced by pain codetermine of
the magnitude of placebo-induced activation of endogenous
opioids; in addition, the location of the ongoing pain
determines how endogenous opioids are somatotopically
activated, hence the location of placebo analgesic eﬀects.
3.3. How Can Robust Placebo Analgesia Be Induced in Speciﬁc
BodyParts? Thisidentiﬁcationofindividualcontributionsof
sensory, cognitive and emotional factors to placebo-induced
activation of endogenousopioidsactually reveals how robust
placebo analgesia can be induced in speciﬁc body parts
throughmanipulatingthesethreefactors. A painfulstimulus
applied in an enhanced cognitive (positive expectations
for this painful stimulus) and emotional (fear and anxiety
induced by the application of this painful stimulus) context
could, as outlined above, to a greater extent activate soma-
totopically organized endogenous opioids, thus producing
enhanced placebo analgesia in the location of the stimulus.
More importantly, if such a cognitively and emotionally
engaged painful stimulus is applied to the site of a clinical
pain, then robust placebo analgesia can be produced in the
site of this clinical pain—that is, the experienced intensity
of this clinical pain can be greatly reduced. Reasoning in
this way, a given clinical pain can be treated by applying
another pain to speciﬁc body parts in an enhanced cognitive
and emotional context. For example, knee pain can be
treated by the application of another pain as a therapy
to the knee. But is there a clinically used placebo therapy
that depends on eﬀectively engaging endogenous opioids
through simultaneously manipulating sensory, cognitiveand
emotional factors? Acupuncture is a likely candidate.
4.IsThere a ClinicallyUsed PlaceboTherapy?
Acupuncture is an ancient Chinese therapy, most commonly
used for pain control, involving inserting needles into
speciﬁc parts of the body. However, its mechanisms of
action are not well understood, and controversy regarding
its clinical eﬃcacy remains [37]. Initially, research attention
has therefore been solely focused on the needle insertion
due to the beliefs that if acupuncture is eﬃcacious it must
be speciﬁcally due to this technical procedure. The essential
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that if acupuncture generates speciﬁc eﬀects superior to its
placebo control. Randomized placebo-controlled trials are
therefore introduced to assess the speciﬁc eﬃcacy of needle
insertion on the basis of the biomedical consideration that
eﬃcacious therapy is therapy that proves to be superior to
its placebo control in a randomized controlled trial. When
the majority of randomized controlled trials of acupuncture
fails to show eﬀects beyond a placebo response [38, 39],
acupuncture has been dismissed as nothing more than
placebo [40]. However, to say that acupuncture is not better
than placebo does not mean that it does nothing. In fact, the
essential issue concerning the eﬀectiveness of acupuncture is
not if acupuncture has more than placebo eﬀects, but rather
how acupuncture can produce such robust placebo eﬀects as
to have clinical relevancy.
4.1. Is Acupuncture an Enhanced Placebo? Research data
support the critical role of beliefs and expectations in the
eﬀectiveness of acupuncture. A recent study concluded that
the eﬀectiveness of acupuncture was signiﬁcantly associated
with higher outcome expectations [41], and therefore how
patients are informed about the trial of acupuncture they
take part in may greatly inﬂuence trial outcomes [42].
Another study went even a step further reporting that
patient’s beliefs and expectations (determined by the per-
ceived assignment to real acupuncture or a placebo) had a
greater impact on treatment outcomes than did the actual
treatment itself [43]. Furthermore, research ﬁndings from
neuroimaging studies on acupuncture analgesia show that
acupuncture may act on similar neural networks as placebo
(expectationsfor reduced pain) in producingpain relief[44–
47]. Indeed, it has been suggested that it is not meaningful
to split acupuncture into speciﬁc and non-speciﬁc elements
and the use of placebo and sham controlled trial designs in
evaluating acupuncture may generate false-negative results
[48]. In line with this suggestion, considering the critical
role played by expectations and beliefs in the eﬀectiveness
of acupuncture, it has been proposed that acupuncture is
actuallyanenhancedplaceboandnecessarilycomprisesthree
integral and indispensable components, which are of the
same importance in ensuring the eﬀectiveness of acupunc-
ture, including needle insertion (spatial-speciﬁc painful
stimulation), culture-enhanced positive beliefs and beneﬁt
expectations for needle stimulation (cognitive context), and
fear and anxiety induced by the perceived invasiveness of
needle insertion (emotional context) [19]. This new view
of acupuncture as an enhanced placebo warrants a new
look at speciﬁc and non-speciﬁc elements involved in the
clinical administration of acupuncture and challenges the
presentconsideration ofrandomized controlled trials asgold
standard in evaluating the eﬃcacy of acupuncture, for it is
unlikely meaningful to evaluate the eﬀectivenessof a placebo
therapy such as acupuncture with placebo-controlled trial
designs.
4.2. Cognitive and Emotional Context Underlying Acupunc-
ture. Culture can have profound impacts on medicine
through shaping individuals’ beliefs [49]. Acupuncture is
deﬁnitely a culture-based therapy embedded in unique
beliefs and rituals [37, 50, 51], allowing patients to
have elevated positive beliefs and beneﬁt expectations on
this therapy. Furthermore, comprehensive and intimate
acupuncturist–patient relationship is another factor con-
tributing to enhanced beneﬁt expectations for this therapy
[52]. Furthermore, fear and anxiety comprise the charac-
teristic emotional context in which acupuncture is admin-
istered. Acupuncture is, at any rate, an invasive procedure
which can never fail to cause considerable levels of fear and
anxiety in the patient while receiving this treatment, even
for those who repeatedly receive this treatment. Actually,
this invasiveness induced fear and anxiety can make great
impacts on the patient’s mind: a wide range of adverse
eﬀects occurring before/during needle administration can
be attributable to the patient’s fear and anxiety, including,
just list a few, severe nausea, actual fainting, severe dizziness,
heavy sweating and vomiting [53].
4.3. Why Does Acupuncture Induce Enhanced Placebo Anal-
gesia? These observations strongly point to the assumption
that acupuncture depends on the administration of invasive
procedures (i.e., needle insertion that produces spatial-
speciﬁc painful stimulation) in an enhanced cognitive and
emotional context to make therapeutic eﬀects. Such three
integral components of acupuncture, as outlined above, can
most eﬀectively activate somatotopically organized endoge-
nous opioids and, thus, generate robust placebo eﬀects in
speciﬁc parts of the body (the location of the target pain).
This is consistent with studies showing that acupuncture
analgesia islargely mediated byendogenousopioids[54–56].
Most importantly, according totraditional Chinese medicine
(TCM) meridian theory, spatial-speciﬁc needle stimulation
induces therapeutic eﬀects only in speciﬁc parts of the body,
not only in the site of needle stimulation (local eﬀects) but
also at some distance from the site of stimulation along a
speciﬁc meridian (distal eﬀects). That is, pain of diﬀerent
locations and tissues origins needs to be treated by inserting
needles into diﬀerent parts of the body. Acupuncture is
therefore a good example of clinically used placebo therapies
which produce clinically relevant placebo responses through
simultaneously manipulating sensory, cognitive and emo-
tional factors. That explains why acupuncture is provided in
such a sophisticated manner and how clinical provision of
acupuncture can elicit robust placebo eﬀects.
The levelofplacebo expectations, which is a major deter-
minant factor of the magnitude of placebo analgesia, varies
greatly across clinical and experimental contexts. At one
end of the scale are less negative expectations for the target
pain (i.e., expectations for the reduction of the target pain)
as with non-invasive placebos such as placebo cream, pills,
words and practitioner-patient relationships, whereas at the
other end of the scale are positive expectations (i.e., positive
beliefs and beneﬁt expectations) for a painful stimulus
administered as a therapy as with invasive placebos such as
acupuncture.There isnodoubtthatpositiveexpectationsare
deﬁnitely diﬀerent in nature from, and obviously of a higher
level than, less negative expectations. Compared with that
less negative expectations for the target pain do not elicit
clinically relevant placebo analgesia, positive expectations4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Compared with non-invasive placebos (such as placebo
creams, pills and words), which induce less negative (neutral at
best) expectations for the target pain, invasive placebos such as
sham surgery and acupuncture induce positive (neutral at least)
expectations for a painful stimulus administered as a therapy, thus
producing clinically relevant placebo analgesia.
for a spatial-speciﬁc painful stimulation induced by invasive
procedures could more eﬀectively activate somatotopically
organized endogenous opioids, thus generating enhanced
placebo analgesia ofclinically relevancy in the location of the
target pain (Figure 1). In short, enhanced placebo responses
of acupuncture do not result directly from less negative
expectations for the target pain but rather indirectly from
positive expectations for needle stimulation administered
as a therapy. Although pain is undoubtedly an aversive
and negative experience and can hardly be associated with
positive expectations, clinical administration of acupuncture
successfully induces positive beliefs and beneﬁt expectations
for a therapeutic pain through which endogenous opioids
can be most eﬀectively activated. Acupuncture can therefore
be viewed as depending on “positive” pain to cure negative
pain.
5.Why Does ShamSurgeryGenerateRobust
PlaceboAnalgesia?
This new accountofenhanced placebo analgesia ofacupunc-
ture is supported by further evidence from randomized
sham-controlled trials of invasive interventions for pain.
Clinical trials of surgery have seldom included placebo
surgery as a control, owing to ethical concerns [57, 58].
However, occasionally used sham-controlled surgical trials
dramatically showed that sham surgical procedures could be
as eﬀective as real procedures in terms of the improvements
in subjective measures such as pain and function [59–
62]. These studies demonstrate how much of the success
of operative procedures for pain reported by observational
trials is due to the placebo eﬀect [63].
Butwhy cansham surgery elicitespecially robustplacebo
analgesia of clinical relevancy? A possible explanation is that
sham surgery depends on the administration of invasive
proceduressuchasskinincisionsandsutures(whichproduce
spatial-speciﬁc painfulstimulation)inanenhancedcognitive
and emotional context to generate robust placebo analgesia.
5.1. Cognitive and Emotional Context Underlying Sham
Surgery. Surgery is particularly meaningful in a culture
rich in machines and tools and therefore induces a pro-
found meaning response in modern medical practice [49,
64, 65]. What features clinical administration of surgery
is enhanced positive beliefs and beneﬁt expectations for
invasive procedures: surgeons are among the elite of medical
practitioners; surgical procedures usually have compelling
rational explanations, which drug treatments often do not;
in addition, the invasive nature itself of surgery is also an
important contributing factor to enhanced positive beliefs
and beneﬁt expectations. Furthermore, there is no doubt
that fear and anxiety comprise the characteristic emotional
context in which surgery is administered, for surgery is
obviously invasive and can cause inevitable pain and most
likely blood shedding.
5.2. Why Does Sham Surgery Elicit Enhanced Placebo Anal-
gesia? On the basis of these considerations, it is reasonable
to propose that sensory (spatial-speciﬁc painful stimulation
induced by sham procedures), cognitive (positive beliefs
and beneﬁt expectations for the painful stimulation) and
emotional (fear and anxiety induced by the perceived inva-
siveness of surgical procedures) factors are simultaneously
engaged by the administration of sham surgery. A combi-
nation of these three factors, as outlined above, could most
eﬀectively activate somatotopically organized endogenous
opioids to produce clinically relevant analgesic eﬀects in
speciﬁc body parts (the location of the target pain). In this
regard, interestingly, sham surgery and acupuncture can be
considered to be analogous in terms of a spatial-speciﬁc
painful stimulus administered in an enhanced cognitive
and emotional context. This proposition is convincingly
supported by research ﬁndings from recent sham-controlled
trials of invasive interventions for pain of various locations.
A large-scale, randomized controlled trial of arthroscopic
surgeryforkneeosteoarthritisreportedthatshamoperations
(which produce spatial-speciﬁc painful stimulation) admin-
istered in the skin of the knee, which elicit robust analgesic
eﬀects in the knee, are no less eﬀective for knee pain than
real procedures [60]. Not coincidently, a recent high-quality
randomized controlled trial of vertebroplasty for painful
osteoporotic vertebral fractures drew similar conclusions
that sham operations administrated in the aﬀected vertebral
body can as eﬀectively reduce pain in that area as real
procedures [62].
6.Conclusion
Previous studies focused on the role of cognitive factors
(expectations and beliefs) in placebo responding. However,
the present hypothesis argues that sensory, cognitive andEvidence-Based Complementary and Alternative Medicine 5
emotional factors are simultaneously at work during placebo
analgesia. Furthermore, clinically relevant placebo analgesia
can be produced in speciﬁc body parts through the manip-
ulation of such three factors as in the case of acupuncture
and sham surgery. That explains why invasive procedures,
such as acupuncture and sham surgery, are better than the
others in terms of eliciting placebo analgesia. Acupuncture
is a clinically used placebo therapy, theory basis and clinical
administration of which highlight one of the best, if not the
best, manners through which enhanced placebo eﬀects can
be produced in speciﬁc body parts (the site of the target
pain). Research into the mode of action of acupuncture will
shed direct light on neural mechanisms underlying placebo
analgesia and vice versa.
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